Saturday, July 25, 2026

pharma · Small Cell Lung Cancer · Metastatic castration-resistant prostate cancer (mCRPC)

Amgen

Amgen trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

One Amgen Center Drive, Thousand Oaks, CA 91320, US HQ
1980 Founded
40,212 Employees
NMPA registrant Type
Company details
Status
Public
HQ
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Founded
1980
Employees
40,212
Programs
2
Drugs
86
Patents
1
Intelligence · Clinical Trials

Amgen clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Amgen programs — each row shows trial ID, program name, phase, status, and indication.

Amgen trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Amgen.

  1. Evolocumab — Phase 3

    Clinical update
  2. EVOLOCUMAB — Approved

    Clinical update

Trial registry

2 studies